Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$628M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$608M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$518M |
| 4 |
Intel
INTC
|
+$172M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 2 |
Amazon
AMZN
|
+$437M |
| 3 |
Microsoft
MSFT
|
+$405M |
| 4 |
NVIDIA
NVDA
|
+$226M |
| 5 |
LyondellBasell Industries
LYB
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.07% |
| 2 | Financials | 5.69% |
| 3 | Healthcare | 5.49% |
| 4 | Consumer Discretionary | 4.41% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Graco
GGG
$13.2B
| $4.79M | ﹤0.01% |
80,694
-34,085
| -30% | -$2.14M |
|
1552
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $4.79M | ﹤0.01% |
93,840
+38,703
| +70% | +$2.02M |
|
|
SGEN
1553
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.78M | ﹤0.01% |
27,000
| – | – |
|
1554
PUT
Datadog
DDOG
$93.8B
| $4.76M | ﹤0.01% |
50,000
| – | – |
|
1555
Dynatrace
DT
$12.9B
| $4.75M | ﹤0.01% |
120,382
-128,573
| -52% | -$5.12M |
|
|
CTLT
1556
DELISTED
CATALENT, INC.
CTLT
| $4.74M | ﹤0.01% |
44,144
-19,878
| -31% | -$2.02M |
|
1557
PUT
Vertex Pharmaceuticals
VRTX
$124B
| $4.73M | ﹤0.01% |
16,800
-118,400
| -88% | -$31.7M |
|
1558
Virgin Galactic
SPCE
$316M
| $4.72M | ﹤0.01% |
39,230
-2,087
| -5% | -$303K |
|
1559
PUT
S&P Global
SPGI
$123B
| $4.72M | ﹤0.01% |
14,000
| – | – |
|
|
TWTR
1560
CALL
DELISTED
Twitter, Inc.
TWTR
| $4.71M | ﹤0.01% |
126,000
-78,000
| -38% | -$3.35M |
|
1561
Repligen
RGEN
$7.01B
| $4.71M | ﹤0.01% |
29,006
-6,414
| -18% | -$1.01M |
|
|
MAXR
1562
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $4.71M | ﹤0.01% |
180,555
+3,448
| +2% | +$107K |
|
1563
Mercury Systems
MRCY
$5.52B
| $4.71M | ﹤0.01% |
73,195
-19,805
| -21% | -$1.18M |
|
|
ZLS
1564
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
| $4.7M | ﹤0.01% |
483,726
| – | – |
|
1565
Flywire
FLYW
$2.06B
| $4.7M | ﹤0.01% |
266,580
+264,404
| +12,151% | +$6.14M |
|
1566
Ironwood Pharmaceuticals
IRWD
$593M
| $4.67M | ﹤0.01% |
404,623
+310,252
| +329% | +$3.65M |
|
1567
Halozyme
HALO
$9.82B
| $4.66M | ﹤0.01% |
105,884
+65,432
| +162% | +$2.83M |
|
1568
Emergent Biosolutions
EBS
$374M
| $4.64M | ﹤0.01% |
149,622
+84,482
| +130% | +$2.88M |
|
1569
Terreno Realty
TRNO
$7.57B
| $4.62M | ﹤0.01% |
82,816
-7,178
| -8% | -$472K |
|
|
APLS
1570
DELISTED
Apellis Pharmaceuticals
APLS
| $4.61M | ﹤0.01% |
101,960
+75,276
| +282% | +$3.43M |
|
1571
H.B. Fuller
FUL
$2.99B
| $4.56M | ﹤0.01% |
75,707
+25,679
| +51% | +$1.72M |
|
1572
State Street SPDR S&P Health Care Equipment ETF
XHE
$162M
| $4.54M | ﹤0.01% |
53,494
+47,846
| +847% | +$4.5M |
|
|
JKS
1573
JinkoSolar
JKS
$774M
| $4.54M | ﹤0.01% |
65,591
-104,869
| -62% | -$5.88M |
|
1574
Boston Beer
SAM
$1.95B
| $4.53M | ﹤0.01% |
14,954
-2,000
| -12% | -$696K |
|
1575
Arcus Biosciences
RCUS
$3.3B
| $4.52M | ﹤0.01% |
178,500
+145,896
| +447% | +$3.57M |
|
Similar funds
Citigroup's Q2 2022 Portfolio in Review
As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
- Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
- Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
- Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
- Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
- Citigroup opened 507 new positions and closed 579 in Q2 2022.
- Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.